XENE - CIK 0001582313
Xenon Pharmaceuticals Inc. has filed 763 documents with the SEC between 2013 and 2026. The most frequent type is insider trade (317 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| SCHEDULE 13G/A | - | 2026-05-15 | - |
| Insider trade | 4 | 2026-05-13 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-07 | 2026-03-31 |
| Major company event | 8-K | 2026-05-07 | 2026-05-07 |
| Annual report to shareholders | ARS | 2026-04-22 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-22 | - |
| Proxy statement | DEF 14A | 2026-04-22 | 2026-04-22 |
| Employee stock plan | S-8 | 2026-04-13 | - |
| Major company event | 8-K | 2026-04-13 | 2026-04-07 |
| Insider trade | 4 | 2026-03-13 | 2026-03-12 |
| Insider trade | 4 | 2026-03-13 | 2026-03-12 |
| Insider trade | 4 | 2026-03-13 | 2026-03-12 |
| Insider sale notice | 144 | 2026-03-13 | - |
| Insider sale notice | 144 | 2026-03-13 | - |
| Insider sale notice | 144 | 2026-03-13 | - |
| Major company event | 8-K | 2026-03-13 | 2026-03-13 |
| Major company event | 8-K | 2026-03-12 | 2026-03-10 |
| Prospectus supplement | 424B5 | 2026-03-12 | - |
| Insider trade | 4 | 2026-03-11 | 2026-03-09 |
| Insider trade | 4 | 2026-03-11 | 2026-03-09 |
| Insider trade | 4 | 2026-03-11 | 2026-03-09 |
| Free writing prospectus | FWP | 2026-03-11 | - |
| Insider sale notice | 144 | 2026-03-10 | - |
| Insider sale notice | 144 | 2026-03-10 | - |
| Insider sale notice | 144 | 2026-03-10 | - |
| Prospectus supplement | 424B5 | 2026-03-09 | - |
| Insider sale notice | 144 | 2026-03-09 | - |
| Major company event | 8-K | 2026-03-09 | 2026-03-09 |
| Major company event | 8-K | 2026-02-27 | 2026-02-27 |
| Prospectus supplement | 424B5 | 2026-02-27 | - |
| Annual report | 10-K | 2026-02-26 | 2025-12-31 |
| Major company event | 8-K | 2026-02-26 | 2026-02-26 |
| SCHEDULE 13G | - | 2026-02-10 | - |
| Insider trade | 4 | 2026-01-09 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 | 2026-01-09 |
| Insider trade | 4 | 2026-01-09 | 2026-01-09 |
| Insider trade | 4 | 2026-01-02 | 2026-01-02 |
| Insider sale notice | 144 | 2026-01-02 | - |
| Insider trade | 4 | 2025-12-09 | 2025-12-05 |
| Insider sale notice | 144 | 2025-12-08 | - |
| Insider sale notice | 144 | 2025-12-05 | - |
| Insider trade | 4 | 2025-12-03 | 2025-11-28 |
| Insider sale notice | 144 | 2025-12-01 | - |
| Employee stock plan | S-8 | 2025-12-01 | - |
| Major company event | 8-K | 2025-12-01 | 2025-11-24 |
| SCHEDULE 13G | - | 2025-11-14 | - |
| Quarterly report | 10-Q | 2025-11-03 | 2025-09-30 |